Nurse Anesthetist - CR in Weslaco, TX Accepting Medicare

6 Nurse Anesthetist - CR nurses found. Showing 1 - 6

Mrs. Julie I Meza, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1401 E 8th St, Weslaco, TX 78596 Phone: 956-969-5267    Fax: 956-969-5497

Djomelle Escano, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1401 E 8th St, Weslaco, TX 78596 Phone: 956-968-8567

Mr. Gabriel Adrian Zorrilla Sr., CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1401 E 8th St, Weslaco, TX 78596 Phone: 956-968-8567

Wendy Saenz, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 2001 Bald Cypress Dr, Weslaco, TX 78596 Phone: 956-854-1358

Mr. Israel Coronado, C.R.N.A. Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1016 S Mile 2 1/2 W, Weslaco, TX 78596 Phone: 956-246-7670

Mr. Joseph Paul Saenz, CRNA, M.S. Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 1401 E 8th St, Weslaco, TX 78596 Phone: 956-968-8567

News Archive

Berwick's exit interview with NY Times: 'I came with an agenda' for improvement

The official in charge of Medicare and Medicaid for the last 17 months says that 20 percent to 30 percent of health spending is "waste" that yields no benefit to patients, and that some of the needless spending is a result of onerous, archaic regulations enforced by his agency. The official, Dr. Donald M. Berwick, listed five reasons for what he described as the "extremely high level of waste." They are overtreatment of patients, the failure to coordinate care, the administrative complexity of the health care system, burdensome rules and fraud.

New vaccine for deadly meningococcus B

A new study shows that a new 4-component meningococcal (4CMenB) vaccine for teenagers is effective when administered on a schedule of 2 doses from 1 to 6 months apart. María Elena Santolaya, from the Department of Pediatrics, University of Chile, Santiago, and colleagues performed the study, which was published online January 18 in the Lancet.

Court rules in favor of Volcano/Axsun against LightLab Imaging

Volcano Corporation said today that the Superior Court of Massachusetts has issued a decision that ruled in favor of Volcano and its wholly-owned subsidiary Axsun Technologies, Inc., and against LightLab Imaging, Inc., on all of LightLab's remaining claims for trade secret misappropriation. The 11-page decision also rejected LightLab's request for injunctive relief.

Study finds significant reduction in hospital admissions with Medicare Part D prescription coverage

A new study by the Johns Hopkins Bloomberg School of Public Health and the University of Illinois at Chicago finds that Medicare Part D prescription coverage significantly reduced hospital admissions and program expenditures totaling $1.5 billion annually.

Teva Pharmaceutical announces new data from PreCISe study

Teva Pharmaceutical Industries Ltd. today announced new data from the five-year extension of the PreCISe study demonstrating that earlier initiation of treatment with Copaxone (glatiramer acetate injection) in patients presenting with first signs of multiple sclerosis (MS), provided greater effects in delaying conversion to clinically definite MS (CDMS) compared to later treatment initiation after diagnosis of CDMS or after three years on the study.

Read more Medical News

› Verified 8 days ago